Wagaarachchi Prabhath T, Ashok Premila W, Smith Norman C, Templeton Allan
Department of Obstetrics and Gynaecology, University of Aberdeen, UK.
BJOG. 2002 Apr;109(4):462-5. doi: 10.1111/j.1471-0528.2002.01075.x.
The aim of this study was to determine the efficacy of mifepristone in combination with sublingual misoprostol for the medical management of early fetal demise. Fifty-six consecutive women were studied prospectively. The mean (SD) gestation at diagnosis was 9.6 weeks (1.84). Four women had complete miscarriage with mifepristone alone. The overall success rate was 83.9% and the median induction-miscarriage interval was 8.19 hours (range 0.83 to 37.50 hours). Of those women who had a successful outcome, 91.5% were satisfied with the regimen. Sublingual misoprostol in combination with mifepristone is an effective and safe alternative to vaginal or oral misoprostol in the management of early fetal demise.
本研究的目的是确定米非司酮联合舌下含服米索前列醇用于早期胎儿死亡药物治疗的疗效。对56名连续的女性进行了前瞻性研究。诊断时的平均(标准差)孕周为9.6周(1.84)。4名女性仅使用米非司酮就完全流产。总体成功率为83.9%,引产至流产的中位间隔时间为8.19小时(范围0.83至37.50小时)。在那些有成功结局的女性中,91.5%对该治疗方案满意。在早期胎儿死亡的治疗中,舌下含服米索前列醇联合米非司酮是阴道或口服米索前列醇的一种有效且安全的替代方法。